Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data

Abstract Introduction An extensive clinical development program showed that the meningococcal serogroup B-factor H binding protein (MenB-FHbp) vaccine affords protection against MenB disease for adolescents and adults. Data were pooled from multiple studies within the program to examine whether MenB...

Full description

Bibliographic Details
Main Authors: Johannes Beeslaar, Paula Peyrani, Judith Absalon, Jason Maguire, Joseph Eiden, Paul Balmer, Roger Maansson, John L. Perez
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-07-01
Series:Infectious Diseases and Therapy
Subjects:
Clinical trial
Immunogenicity
Invasive meningococcal disease
Serogroup B
Vaccines
Online Access:https://doi.org/10.1007/s40121-020-00322-5

Internet

https://doi.org/10.1007/s40121-020-00322-5

Similar Items